EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Refined ADME Profiles for ATC Drug Classes

Luca Menestrina iD, Raquel Parrondo-Pizarro iD, Ismael Gómez, Ricard Garcia-Serna, Scott Boyer, Jordi Mestres iD

Pharmaceutics · 28.02.2025 · 17 (3) · 308

DOI: 10.3390/pharmaceutics17030308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 28.02.2025. Verfasst von Luca Menestrina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chemotargets SL, Parc Cientific de Barcelona, Baldiri Reixac 4 (TR-03), 08028 Barcelona, Catalonia, Spain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Modern generative chemistry initiatives aim to produce potent and selective novel synthetically feasible molecules with suitable pharmacokinetic properties. General ranges of physicochemical properties relevant for the absorption, distribution, metabolism, and excretion (ADME) of drugs have been used for decades. However, the therapeutic indication, dosing route, and pharmacodynamic response of the individual drug discovery program may ultimately define a distinct desired property profile.

Methods

A methodological pipeline to build and validate machine learning (ML) models on physicochemical and ADME properties of small molecules is introduced.

Results

The analysis of publicly available data on several ADME properties presented in this work reveals significant differences in the property value distributions across the various levels of the anatomical, therapeutic, and chemical (ATC) drug classification. For most properties, the predicted data distributions agree well with the corresponding distributions derived from experimental data across fourteen drug classes.

Conclusions

The refined ADME profiles for ATC drug classes should be useful to guide the de novo generation of advanced lead structures directed toward specific therapeutic indications.

Schlagwörter

Stichwörter der Autor:innen

ADMEAI drug discoveryAI/ML modelsATC classificationdrug classesgenerative chemistrypharmacokineticsphysicochemical properties

Autor:innen und Institutionen

  • Chemotargets SL, Parc Cientific de Barcelona, Baldiri Reixac 4 (TR-03), 08028 Barcelona, Catalonia, Spain.
  • Institut de Quimica Computacional i Catalisi, Facultat de Ciencies, Universitat de Girona, Maria Aurelia Capmany 69, 17003 Girona, Catalonia, Spain.

ORCID-Profile: Luca Menestrina, Raquel Parrondo-Pizarro, Jordi Mestres

Zitieren

APA

Menestrina, L., Parrondo-Pizarro, R., Gómez, I., Garcia-Serna, R., Boyer, S., & Mestres, J. (2025). Refined ADME Profiles for ATC Drug Classes. Pharmaceutics, 17(3), 308. https://doi.org/10.3390/pharmaceutics17030308

Vancouver

Menestrina L, Parrondo-Pizarro R, Gómez I, Garcia-Serna R, Boyer S, Mestres J. Refined ADME Profiles for ATC Drug Classes. Pharmaceutics. 2025;17(3):308. doi:10.3390/pharmaceutics17030308

BibTeX
@article{Menestrina2025,
  author = {Menestrina, Luca and Parrondo-Pizarro, Raquel and Gómez, Ismael and Garcia-Serna, Ricard and Boyer, Scott and Mestres, Jordi},
  title = {Refined ADME Profiles for ATC Drug Classes},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {308},
  doi = {10.3390/pharmaceutics17030308}
}
Kostenlos starten →